Keywords: viral, drug, promising, prostate, cancer, biotechnology, firm

Viral drug promising in prostate cancer

Article | 26 October 2001

Print This

US biotechnology firm Cell Genesys has reported encouraging data from aPhase I/II trial of CG7870 (formerly CV787), a virus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in